![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 34, 30976-30983, August 23, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 25, 2002, and in revised form, May 28, 2002
The crystal structure of the
NADH-dependent bacterial flavoenzyme morphinone reductase
(MR) has been determined at 2.2-Å resolution in complex with the
oxidizing substrate codeinone. The structure reveals a dimeric enzyme
comprising two 8-fold The flavoenzyme morphinone reductase
(MR)1 from Pseudomonas
putida is a member of the Old Yellow Enzyme (OYE) family of
proteins (1). MR catalyzes the NADH-dependent saturation of
the carbon-carbon bond of both morphinone and codeinone. The products
of these reactions, hydromorphone and hydrocodone, are valuable
semi-synthetic opiate drugs; hydromorphone is a powerful analgesic
(seven times more potent than morphine (2)), and hydrocodone is a mild
analgesic and antitussive (3). The synthesis of both compounds is
complicated owing to difficulty in specifically oxidizing the C-6
hydroxy group of morphine and the often limiting supply of thebaine (a precursor for the synthesis of hydrocodone). These shortcomings have
led to the development of novel recombinant biocatalytic routes for
hydromorphone and hydrocodone synthesis (4). Biological synthesis
exploits the ability of Escherichia coli, transformed with the genes encoding morphinone reductase and morphine dehydrogenase and fed with morphine or codeine, to accumulate hydromorphone and
hydrocodone, respectively (5, 6).
MR is a dimeric flavoenzyme of Mr 82,200 (1). It
contains one molar equivalent of non-covalently bound FMN per enzyme
subunit, and based on sequence similarity studies it belongs to the
Class I flavin-dependent The crystallographic structures of three members of the Class I
subfamily of MR shares with the other Class I subfamily members the ability to
reduce a number of 2-cyclic enones and to form complexes with steroids
(27). However, MR is distinct in its ability to reduce the unsaturated
carbon-carbon bond of a number of opiate compounds (27). Sequence
alignment studies also suggest differences in the chemical nature of
the active site of MR compared with OYE and PETN reductase (1). To
investigate these aspects, and to provide a structural basis for
detailed mechanistic studies of MR, we have solved the structure of MR
in complex with the opiate substrate codeinone at 2.2-Å resolution.
The structure is discussed in the context of the mechanism of opiate
reduction and in view of the existing structural information for PETN
reductase and OYE.
Materials--
All materials were of analytical grade. Codeinone
was a gift from MacFarlan Smith (Edinburgh, Scotland). Mimetic Yellow 2 affinity chromatography resin was from Affinity Chromatography Ltd.
Q-Sepharose resin was from Amersham Biosciences.
Protein Purification and Mutagenesis--
MR was purified from a
recombinant strain of E. coli expressing the enzyme from the
cloned mor B gene as described previously (27) but also incorporating a final chromatographic step using Q-Sepharose. In this latter step, enzyme was applied to a Q-Sepharose column (8.5 cm × 5 cm) equilibrated with 30 mM Tris
buffer, pH 8.0, containing 2 mM 2-mercaptoethanol (buffer
B). The column was washed with 2 liters of buffer B containing 230 mM NaCl and the enzyme was eluted using a gradient of NaCl
(250-500 mM) contained in buffer B. For long term storage,
MR was kept at Crystal Growth--
Initial crystallization conditions for the
enzyme have been described elsewhere (28), but conditions were refined
in the course of the work described here. The optimum crystals were
grown from 15-25% monomethyl polyethylene glycol 550, 0.1 M HEPES, 0.1 M NaCl, 1 mM
dithiothreitol, pH 6.5-7.5, using the sitting-drop vapor diffusion
method. Crystals of the codeinone-enzyme complex were isolated by
soaking the crystals in a solution comprising 1 mM
codeinone, 10 mM phosphate buffer, and 30% monomethyl
polyethylene glycol at pH 6.2 for 20 min. The crystals could be
flash-frozen directly, and data were collected in the home laboratory.
The crystals belong to space group
I212121 with cell dimensions
a = 49.9Å, b = 121.7 Å, and
c = 178.2 Å and contain one molecule per asymmetric unit.
X-ray Data Collection--
Data sets were obtained from single
crystals mounted in rayon loops and cooled to Structure Solution and Refinement--
The structure was solved
by molecular replacement using AMoRe (31) with a model based on OYE
(Protein Data Bank code 1OYA) (21). The correct solutions to the
rotation function had the highest peaks with a correlation coefficient
of 14.8l; the next highest peaks had a value of 9.5. The translation
function solution gave a coefficient of 29.1; this increased to a value
of 40.2 upon rigid-body refinement (R = 49.4% for data
in the range 20-4.0 Å). The starting model was made using the
sequence alignment of French et al. (10); all non-conserved
side chains were truncated to alanine or glycine ,and all insertions in
the OYE sequence were deleted. FMN was not included in these molecular
replacement calculations, but calculation of difference maps showed
clear density for the cofactor, confirming that the correct solution had been chosen. Subsequent refinement was carried out with XPLOR version 3.843 (32). The model was broken into 12 segments (determined by secondary structure), and each segment was refined as a rigid body.
Inspection of sigmaA (33) and Fo Kinetic Studies--
All kinetic studies were performed under
strict anaerobic conditions (<5 ppm of O2) within a glove
box environment (Belle Technology) to prevent oxidase activity of MR.
Steady-state assays were performed using a Jasco V530 spectrophotometer
at 25 °C. Reaction buffer was 50 mM potassium phosphate,
pH 7.0, which was made anaerobic by bubbling with humidified Pureshield
argon at 5 p.s.i. for 2 h prior to introduction into the
glove box. NADH solutions were made from pre-weighed powder and
anaerobic buffer inside the glove box, and the concentration was
determined spectrophotometrically (
Stopped-flow kinetic experiments were performed under anaerobic
conditions using an Applied Photophysics SX.17MV stopped-flow instrument, and transients were analyzed using non-linear least squares
regression using Spectrakinetics software (Applied Photophysics). Averages of five to seven individual transients were analyzed. The
enzyme was contained in 50 mM potassium phosphate buffer, pH 7.0. In the reductive half-reaction, enzyme (20 µM)
was mixed with NADH at different concentrations (at least >5-fold the
enzyme concentration to ensure pseudo-first order conditions). Flavin reduction was monitored at 462 nm; formation and decay of the enzyme-NADH charge-transfer species was monitored at 552 nm (36). In
studies of the oxidative half-reaction, MR was titrated with sodium
dithionite to produce the 2-electron-reduced form of MR. Reduced MR (20 µM) was then mixed with 2-cyclohexenone at different concentrations, and flavin oxidation was monitored at 462 nm. Equations
used to analyze the reductive half-reaction have been described
elsewhere (36). Analysis of the transients obtained for the oxidative
half-reaction is described under "Results."
Overall Structure--
The structure of MR was determined at
2.2-Å resolution by molecular replacement using OYE as the search
model. The structure reveals an 8-fold Active Site Structure in Relation to Other Members of the OYE
Family--
The active site structure of MR is presented in Fig.
2A, alongside those for OYE
and PETN reductase. Important differences in the active site of MR can
be discerned. Tyr-196 in OYE is known to function as an active site
acid in the oxidative half-reaction with
The nature of the flavin contacts in MR (Fig. 2B) are
essentially identical to those described for OYE, except the O3 atom of
the ribityl hydroxyl group is H-bonded to Asn-275 in MR, whereas in OYE this interaction is absent. A key interaction with the flavin is
that made by residue Arg-238. The side chain of this group is located
close to the N-1/C-2 carbonyl region of the flavin isoalloxazine ring,
where it is expected that negative charge will develop during enzyme
reduction. Although the positioning of a positively charged side chain
in this region in many flavoproteins has been postulated to stabilize
developing negative charge (and thus facilitate flavin reduction), our
recent mutagenesis studies with MR indicate that Arg-238 is not
required to stabilize the reduced flavin (39). This finding is in stark
contrast to similar work on lactate monooxygenase, where mutation of
the positively charged residue at this region (Lys-266 to Met-266)
impairs flavin reduction by substrate (40).
NADH is the natural coenzyme preference of MR. In contrast, PETN
reductase, like OYE, has a strong preference for NADPH. The mode of
binding NADPH in OYE is not clear; crystallographic studies with the
NADP analogue (c-THN)TPN show changes in electron density, but more
than one interpretation for the ADP portion has been presented (21). In
the absence of a model for coenzyme binding, it is difficult to account
for the differences in coenzyme specificity between the family members.
Preference for NADPH is often conferred by the presence of two arginine
residues in the vicinity of the 2'-phosphate group of the coenzyme (41,
42), although it is important to note that these preferences are
derived from a different protein fold. In NADH-dependent
dehydrogenases these arginine residues are absent, and an acidic
residue (aspartate or glutamate) forms a hydrogen bond to the
2'-hydroxy group of NADH (41, 42). In searching for residues that
confer coenzyme preference in the OYE family, we note from modeling
studies in which the NMN (nicotinamide mononucleotide) portion
of the coenzyme adopts a conformation similar to that seen in OYE (21)
that the polypeptide excursion between Crystal Soak Experiments--
We have made a number of attempts to
soak ligands into the active site of crystalline MR. Our studies have
included soaking steps with NADH and the oxidizing substrates
2-cyclohexenone and codeinone. Upon soaking crystals with NADH, the
yellow appearance of the crystals fades indicating reduction of the
enzyme-bound FMN. This reduction of the flavin occurs without crystal
cracking, but analysis of frozen crystals showed no evidence for the
presence of coenzyme in the active site. Our observations suggest that NADP+ and NADPH have relatively low affinities for reduced
enzyme, consistent with a ping-pong reaction mechanism (27) and with the known moderate affinity of reduced OYE for NADP+ (43).
Similarly, analysis of crystals soaked with 2-cyclohexenone showed no
evidence of ligand binding in the active site. In contrast, we have had
some limited success in analysis of crystals soaked with the oxidizing
substrate codeinone. The active site of the MR-codeinone complex
clearly shows a large peak of electron density that is not seen in the
absence of codeinone. The density is difficult to interpret
unambiguously and suggests that codeinone binds in more than one
orientation. The density is located over the si-face of the
flavin in a region similar to that seen with ligands of PETN reductase
(22) and OYE (21). Possible interpretations of the density for
codeinone are included in the header of the Protein Data Bank entry.
Properties of the C191A Mutant Enzyme--
Inspection of the
active site of MR and comparison with the active site structures of OYE
and PETN reductase reveals that the conventional active site acid
(Tyr-196 in OYE and Tyr-186 in PETN reductase) is absent in MR. A
common feature of these enzymes is their ability to reduce the olefinic
bond of 2-cyclohexenone. The crystal structure of PETN reductase solved
in the presence of 2-cyclohexenone reveals that Tyr-186 is ideally
placed to protonate the substrate following reduction of the olefinic
bond by hydride transfer from the flavin N5 (26) (Fig.
3A). Mutagenesis of Tyr-196 in
OYE has also confirmed that this residue donates a proton to 2-cyclohexenone in the oxidative half-reaction (37). Given that MR also
catalyzes the reduction of the olefinic bond in 2-cyclohexenone, we
were interested to learn if Cys-191 (the equivalent of Tyr-196 in OYE
and Tyr-186 in PETN reductase) could serve as a proton donor in the
reduction of 2-cyclohexenone and codeinone.
Apparent kinetic parameters determined under steady-state conditions
using 2-cyclohexenone as oxidizing substrate for both the wild-type and
C191A MR enzymes are displayed in Table
II. The C191A mutant enzyme retains the
ability to reduce 2-cyclohexenone, suggesting that Cys-191 does not
play a major role in catalysis. The most pronounced effect on the
steady-state kinetic parameters is ~2.5-fold reduction in apparent
kcat on converting Cys-191 to alanine. We
investigated the kinetics of the reductive and oxidative half-reactions
of the wild-type and C191A enzymes to ascertain if the reduction in
apparent kcat is associated with impaired flavin
reduction or oxidation. Detailed studies of the reductive half-reaction
of wild-type MR with NADH as reducing substrate have been reported
elsewhere (36) at 278 K, but corresponding studies of the oxidative
half-reaction using 2-cyclohexenone as substrate were not reported.
Herein, we report the kinetic behavior of both the C191A and wild-type
enzyme with NADH, 2-cyclohexenone, and codeinone (determined at 283 K).
The kinetic scheme for the reductive half-reaction is shown in Scheme
1. The minimal kinetic scheme (Scheme 1)
is slightly modified compared with that presented in Craig et
al. (36) (Scheme 2) in that an
additional enzyme-NADH complex is shown prior to formation of the
enzyme-NADH charge-transfer complex. Inclusion of this complex is
consistent with work on OYE (43) and EBP (44), although direct evidence
for its formation was lacking in our previous studies with wild-type MR
(36). However, our studies with C191A MR suggest that such a species
might exist prior to formation of the charge-transfer species (see
below). Kinetic transients for flavin reduction and formation of the
enzyme-NADH charge-transfer intermediate and plots of observed rate as
a function of NADH concentration are shown in Fig. 3 for wild-type and
C191A MR. As reported previously for wild-type MR, the rate of
formation of the charge-transfer species (observed at 552 nm) is
linearly dependent on NADH concentration, whereas the observed rate for flavin reduction is independent of NADH concentration in the range 125-675 µM. The observed rates of flavin reduction for
wild-type and C191A MR enzymes are essentially identical (22 and 21 s
The kinetic behavior of the oxidative half-reaction was investigated
using 2-cyclohexenone as oxidizing substrate by mixing with MR that had
been reduced at the 2-electron level with dithionite. Recovery of the
flavin absorption was observed at 462 nm, and transients were found to
be biphasic (Fig. 4). The fast phase contributed >90% of the total amplitude change. Fitting to a standard biphasic expression revealed that the observed rate for this phase was
dependent on 2-cyclohexenone concentration, and data were analyzed by
fitting to the rapid equilibrium formalism of Strickland et
al. (45) (Fig. 4). The observed rate for the slow phase (0.02 and
0.01 s
Owing to the very limited supplies of codeinone and difficulties
encountered with its stability under stopped-flow conditions, we were
unable to conduct an extensive study of the concentration dependence of
the oxidative half-reaction with this substrate. However, we were able
to collect a small number of kinetic transients for enzyme oxidation by
codeinone. Fig. 5 illustrates kinetic transients obtained by mixing 2-electron-reduced MR (i.e.
enzyme reduced with a stoichiometric concentration of NADH) with
codeinone (2 mM). At 650 nm, a charge-transfer species
accumulates prior to hydride transfer to codeinone (consistent with our
previous work with wild-type MR (36)) for both wild-type and C191A MR. The formation of the charge-transfer species occurs with similar kinetics in both enzymes (608 and 490 s Concluding Remarks--
At the subunit level, the
structure of MR reveals a close structural similarity with OYE and PETN
reductase, but the interactions that direct subunit-subunit association
are fundamentally different from those reported for OYE. Comparison of
the structures of PETN reductase (NADPH-specific) and MR
(NADH-specific) suggest a region located in a polypeptide excursion
between *
This work was supported by grants from the Biotechnology and
Biological Sciences Research Council (to P. C. E. M., N. C. B., and N. S. S.), the Wellcome Trust, and the Lister Institute of Preventive Medicine.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1GWJ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
Present address: EMBL Grenoble Outstation, 38042 Grenoble cedex 9, France.
**
To whom correspondence may be addressed. Tel.: 44-1-16-252-3366;
Fax: 44-1-16-252-3473; E-mail: pcem1@le.ac.uk.
Published, JBC Papers in Press, June 3, 2002, DOI 10.1074/jbc.M202846200
The abbreviations used are:
MR, morphinone
reductase;
OYE, Old Yellow Enzyme;
PETN, pentaerythritol tetranitrate;
EBP, estrogen binding protein;
(c-THN)TPN,
Crystal Structure of Bacterial Morphinone Reductase and
Properties of the C191A Mutant Enzyme*
,
,
§,
, and
**
Department of Biochemistry, University of
Leicester, University Road, Leicester LE1 7RH and the
¶ Institute of Biotechnology, University of Cambridge, Tennis
Court Road, Cambridge CB2 1QT, United Kingdom
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
/
barrel domains, each bound to FMN, and a
subunit folding topology and mode of flavin-binding similar to that
found in Old Yellow Enzyme (OYE) and pentaerythritol tetranitrate
(PETN) reductase. The subunit interface of MR is formed by interactions
from an N-terminal
strand and helices 2 and 8 of the barrel domain
and is different to that seen in OYE. The active site structures of MR,
OYE, and PETN reductase are highly conserved reflecting the ability of these enzymes to catalyze "generic" reactions such as the reduction of 2-cyclohexenone. A region of polypeptide presumed to define the
reducing coenzyme specificity is identified by comparison of the MR
structure (NADH-dependent) with that of PETN reductase (NADPH-dependent). The active site acid identified in OYE
(Tyr-196) and conserved in PETN reductase (Tyr-186) is replaced by
Cys-191 in MR. Mutagenesis studies have established that Cys-191 does not act as a crucial acid in the mechanism of reduction of the olefinic
bond found in 2-cyclohexenone and codeinone.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
/
barrel oxidoreductases (1,
7). The Class I subfamily includes the isoforms of OYE (8), estrogen binding protein (EBP) from Candida albicans (9),
pentaerythritol tetranitrate (PETN) reductase (10), glycerol trinitrate
reductase (11), the xenobiotic reductases of Pseudomonas
species (12), and 12-oxophytodienoic acid reductase from tomato (13)
and Arabidopsis thaliana (14). MR is also related to
the more complex bile acid-inducible flavoenzymes Bai H and Bai C (15),
the bacterial Fe/S flavoenzymes tri- and dimethylamine dehydrogenases
(16, 17), and the NADH oxidase of Thermoanaerobium brockii
(18). These latter enzymes utilize diverse substrates, but the
catalytic framework has clearly evolved from a common progenitor
(7).
/
flavin oxidoreductases have been reported, including that of the complex iron-sulfur flavoprotein trimethylamine dehydrogenase (19, 20). The structures of OYE and a number of ligand
complexes of OYE have been reported (21), although the physiological
substrate of the enzyme remains elusive. More recently, we reported
structures of PETN reductase and complexes of PETN reductase with
steroid inhibitors and substrates (22). The folds of both OYE and PETN
reductase comprise an 8-fold
/
barrel and reveal the presence of
FMN bound at the C-terminal ends of the internal
-strands. The
active sites are highly conserved, which reflects the ability of OYE
and PETN reductase to reduce the unsaturated bond of a number of
2-cyclic enones (23, 24). Additionally, PETN reductase has been shown
to catalyze the denitration of nitroester explosives, the reduction of
nitroaromatic explosives such as trinitrotoluene and picrate and
degradation of the nitramine explosives (Royal Demolition Explosive
(RDX)) (25, 26).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
80 °C in 50 mM potassium phosphate
buffer, pH 7.0. The C191A mutant MR was isolated using the QuikChange
mutagenesis protocol (Stratagene) and the following oligonucleotides:
5'-GTC CAC GCC GCC AAC GCC GCG CTG CCC AAC CAG TTC CTC-3' and 5'-GAG
GAA CTG GTT GGG CAG CGC GGC GTT GGC GGC GTG GAC-3'. Plasmid pMORB3 (1)
was used as template for the mutagenesis reactions. The mutant gene was completely sequenced to ensure that spurious changes had not arisen during the mutagenesis reaction. Expression and purification of the
C191A MR enzyme was as described for wild-type enzyme.
173 °C in a gas
stream of N2. Three sets of data were used in the course of
the work described here. The original data (2.5 Å) were collected
using a RAXIS IIc image plate device mounted on a Rigaku rotating anode
source with MSC/Yale mirrors. Subsequent 2.36-Å data were recorded at
Station 7.2 of SRS (Synchrotron Radiation Source) Daresbury
Laboratory with an MAR 180 image plate device, and final 2.2-Å
data were recorded using a RAXIS IV image plate device mounted on a
Rigaku rotating anode source with MSC/Yale mirrors. Data were processed
and reduced using DENZO and SCALEPACK (29). Data statistics are
presented in Table I. A random 5% set of
the possible reduced data was selected and used to flag reflections for
the calculation of free R values (30) in all data sets.
Data collection and refinement statistics for crystals of MR reductase
and its complex with codeinone
Fc maps was performed with XTALVIEW (34), and
rebuilding was followed by simulated annealing and positional
refinement. Further rounds of rebuilding and refinement reduced
R (Rfree) for the data for 20-2.5 Å to 36.1% (38.0%) with 80 water molecules. The 2.36-Å data were
collected from a crystal soaked with codeinone, and refinement was
continued using CNS 0.5 (32). This included further rounds of
rebuilding and refinement (both positional and temperature-factor) resulting in a model with R (Rfree)
for data for 40-2.36 Å of 24.5% (28.1%). No interpretable density
was seen in the active site, and further codeinone soaking steps were
tried. The final 2.2-Å data were collected with a crystal
soaked as described above. Refinement with these data used CNS 1.0 (32)
and gave final values for R and Rfree
of 20.5% and 21.6%. Codeinone was built into difference density using
atomic parameters extracted from the Cambridge Structural Data base
through the Chemical Data base Service at Daresbury Laboratory. The
parameters for refinement were calculated with XPLOR2D (35). Refinement
statistics and final model parameters are presented in Table I. The
2.2-Å data and coordinate files have been deposited with the Protein
Data Bank (accession code 1GWJ).
340 = 6220 M
1 cm
1). Solutions of
2-cyclohexenone were made by dilution of a stock (10 M)
into anaerobic buffer. The initial velocity in steady-state assays was
determined from absorbance changes at 340 nm in a reaction cell volume
of 1 ml; the desired concentration of substrate and cofactor solutions
was achieved by making microliter additions to the cell. Least squares
fitting procedures to the standard Michaelis-Menten equation were
performed using Origin (v6) software (Microcal).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
/
barrel with
non-covalently bound FMN located toward the center and C-terminal
end of the barrel (Fig. 1A). The overall subunit structure is similar to that reported for OYE (21)
and PETN reductase (22). However, it is closer to PETN reductase in
that it has a
-loop excursion (comprising of residues 131-151)
between
strand 3 and
-helix 3 of the core barrel domain instead
of the helix found in OYE. Additionally,
-strands A and B form a cap
at the N-terminal domain of the barrel, as seen also in OYE
(21) and PETN reductase (22). MR is dimeric, and the structure of the
dimer (Fig. 1B) reveals that the subunit interactions are
different from those reported for OYE (21). In OYE, the dimer interface
involves helices 4, 5, and 6 of the
/
barrel, but in MR the
interface is less extensive and comprises interactions between the
N-terminal
strands (strands A and B, Fig. 1B) and
helices 2 and 8 of the barrel domain. The dimer interface in MR is not
part of the highly conserved region identified by Fox and Karplus in
their analysis of OYE (21). In addition, in MR the C-terminal excursion
of one subunit extends over the dimer interface and interacts with the
corresponding extension from the second subunit (Fig. 1B).
This C-terminal extension also partially defines the entrance to the
active site of MR along with the polypeptide excursion found between
strand 3 and
-helix 3 of the core barrel domain.

View larger version (51K):
[in a new window]
Fig. 1.
A, structure of a single subunit
of MR illustrating the location of the N-terminal cap (
-strands A
and B) and the polypeptide excursion incorporating
-strands C and D
located between
-helix 3 and
-strand 3 of the barrel core. The
location of the FMN cofactor is shown at the C-terminal end of the
barrel domain in ball-and-stick format. B, an
orthogonal view of the overall structure of MR illustrating the
interactions between the two subunits. Subunit interactions formed by
residues in helices 1, 2, and 8 and the external
strands A and B
are shown. The graphics image was produced using MOLSCRIPT (46).
/
unsaturated enones
(37). This residue is conserved in PETN reductase (Tyr-186), but in MR
the equivalent residue is Cys-191. The active site of MR is larger than
the corresponding site in OYE. This is primarily due to the presence of
a largely hydrophobic insertion (residues Arg-291 to Glu-301) in OYE
that is absent in MR, which lines the entrance to the active site close to the dimethylbenzene subnucleus of the flavin isoalloxazine ring.
Wider access to the active site no doubt reflects the ability of MR to
bind more bulky and conformationally restrained substrates such as
codeinone and morphinone. His-191 and Asn-194 in OYE, which are
involved in ligand binding (21, 38), are conserved in MR as His-186 and
Asn-189.

View larger version (17K):
[in a new window]
Fig. 2.
Active site structure of MR and
protein-flavin interactions in MR. A, superposition of
the active sites of MR, OYE, and PETN reductase. The
numbering of residues is according to that for MR.
Asn-189 and His-186 are equivalent to Asn-194 and His-191 of OYE, which
are known to be involved in the binding of ligands in the active site
of OYE. In PETN reductase the equivalent residue to Asn-189 of MR is a
histidine. In OYE and PETN reductase Cys-191 is replaced by tyrosine;
this latter group is known to be a proton donor in OYE. Acetate is
shown bound to PETN reductase as seen in the crystallographic structure
of this enzyme (22). Colors used are: OYE, yellow; MR,
magenta; PETN reductase, cyan. B,
amino acid residues in direct contact with the FMN in MR.
-strand 3 and
-helix 3 of
the core barrel domain might be positioned appropriately to form
interactions with the distal part of the coenzyme. In PETN reductase
two arginine residues (Arg-142 and Arg-130) are candidates to confer
specificity for NADPH. In contrast, in the NADH-dependent
MR these residues are absent and an acidic residue (Glu-135 for MR) is
present. We suggest this region of the protein might be important in
conferring coenzyme specificity. In OYE, however, the polypeptide
excursion between
-strand 3 and
-helix 3 is replaced by a
-helix. If our proposed site for coenzyme recognition is correct,
then the mode of interaction of the coenzyme in this region of OYE is
different from that in PETN reductase and MR, making general
conclusions concerning coenzyme recognition in the family difficult.
However, there are a number of acidic and basic residues in this region
of OYE that could form interactions with the reducing coenzyme in OYE.
Our future studies are now focused on defining those residues that
interact with NADH by mutagenesis and kinetic methods.

View larger version (24K):
[in a new window]
Fig. 3.
Kinetic transients and plots of rate
versus coenzyme concentration for the reductive
half-reactions of wild-type and C191A MR. Conditions: 50 mM potassium phosphate buffer, pH 7.0; 283 K. A,
transient observed for the C191A mutant MR at 550 nm; NADH
concentration 200 µM. B, transient observed at
462 nm for the C191A mutant MR; NADH concentration 200 µM. Similar transients were obtained for wild-type MR,
and examples of these can be found in our previous paper (36).
C, plot of observed rate versus NADH
concentration for the wild-type enzyme. Filled circles,
observed rate for formation of the NADH-enzyme charge-transfer species;
unfilled circles, observed rate for flavin reduction.
D, same as for panel C, but for C191A MR.
Apparent kinetic parameters determined from steady-state assays of
wild-type and C191A mutant MR enzymes
1, respectively). The second order rate constant for
formation of the charge-transfer species with C191A MR (6.2 ± 0.1 × 105 M
1
s
1) is approximately one-half the value measured for
wild-type MR (12.3 ± 0.4 × 105
M
1 s
1). For Scheme 2, the value
of the positive intercept of the ordinate axis (29 ± 14 and
93 ± 8 s
1 for wild-type and C191A, respectively)
approximates to k2 + k
1. Additionally, the observed rate of flavin
reduction (~20 s
1 for both enzymes) is independent of
NADH concentration (Fig. 3). An approximate value of 9 and 70 s
1 for k
1 can therefore be
estimated for wild-type and C191A, respectively. This gives rise to
values of ~7 and ~113 µM, respectively, for the
enzyme-NADPH dissociation constant in wild-type and C191A MR. For the
wild-type enzyme, the lack of a concentration dependence on the flavin
reduction rate in the range 125-675 µM is therefore consistent with Scheme 2 and a dissociation constant for the
charge-transfer complex of 7 µM. However, the elevated
dissociation constant for the C191A mutant is inconsistent with Scheme
2, because one expects a concentration effect on the flavin reduction
rate at relatively low NADH concentrations. The lack of such
concentration dependence would be consistent with the more complex
Scheme 1, which has been shown for the MR-related enzymes OYE and EBP.
Our data for C191A is therefore more consistent with a scheme (Scheme
1) in which a NADH-enzyme complex accumulates prior to formation of the
charge-transfer intermediate, where the formation of this complex is
rapid (occurring in the dead-time of the stopped-flow apparatus). On
the basis of the above arguments it would seem plausible that the same
rapid formation of a NADH-enzyme complex prior to formation of the
charge-transfer species also occurs in wild-type MR. In this regard, it
is important to note that Scheme 1 is not inconsistent with the
observed kinetic behavior seen for wild-type MR.

View larger version (7K):
[in a new window]
Scheme 1.
![]()
View larger version (4K):
[in a new window]
Scheme 2.
1 for the wild-type and C191A mutant enzymes,
respectively) was independent of 2-cyclohexenone concentration, and the
origin of this relatively small absorbance change is uncertain.
Analysis of the fast phases for the wild-type and C191A MR enzymes
using the Strickland equation yielded limiting rate constants of
0.9 ± 0.02 and 0.32 ± 0.01 s
1, respectively.
The corresponding dissociation constants for the reduced
enzyme-2-cyclohexenone complex are 5.7 ± 0.5 and 11.7 ± 0.9 mM, respectively. The values of the limiting rate constants for flavin oxidation are similar to the apparent
kcat values measured under steady-state
reactions (Table II). The stopped-flow data indicate, therefore, that
flavin oxidation is rate-limiting in steady-state turnover and that
mutation of Cys-191 leads to a reduction in kcat
by compromising the rate of hydride transfer from the flavin N5 to the
olefinic bond of 2-cyclohexenone.

View larger version (22K):
[in a new window]
Fig. 4.
Kinetic transients and plots of rate
versus 2-cyclohexenone concentration for the oxidative
half-reactions of wild-type and C191A MR. Conditions: 50 mM potassium phosphate buffer, pH 7.0; 283 K. A,
transient observed for wild-type MR at 462 nm; 2-cyclohexenone
concentration 2 mM. B, transient observed for
the C191A mutant MR at 462 nm; 2-cyclohexenone concentration 2 mM. C, plot of observed rate (fast phase)
versus concentration of 2-cyclohexenone. The solid
line is the fit to the rapid equilibrium formalism of Strickland
et al. (45); the lack of an intercept on the ordinate axis
illustrates the absence of a reverse reaction. D, same as
for Panel C but for C191A mutant MR. See text for kinetic
parameters determined from the fitting processes.
1 for wild-type
and C191A, respectively). Flavin re-oxidation observed at 462 nm gives
rise to biphasic transients; the rates of both phases are ~4-fold
less in C191A MR, but it is important to emphasize that these are not
limiting rate constants. The transients indicate, however, that
mutation of Cys-191 does not substantially impair the oxidative
half-reaction when codeinone is used as the oxidizing substrate.
Reactions with codeinone are faster than with 2-cyclohexenone by a
factor of about 103, suggesting that the olefinic bond of
codeinone is more optimally aligned with the flavin N5 atom in reduced
enzyme compared with the olefinic bond in 2-cyclohexenone. Our data
rule out the possibility that Cys-191 acts as a crucial active site
acid in the mechanism of reduction of 2-cyclohexenone and codeinone.
The identity of the key acid will be explored in future studies by
mutagenesis and kinetic studies.

View larger version (23K):
[in a new window]
Fig. 5.
Transients obtained for the oxidation of
wild-type and C191A MR by codeinone. Conditions: 50 mM
potassium phosphate buffer, pH 7.0; 283 K. A, kinetic
transient observed at 650 nm for the reaction of NADH-reduced wild-type
MR with codeinone (2 mM); fast rate (increase in
absorption), 608 s
1, slow rate (decrease in absorption),
119 s
1. B, same as for Panel A but
for C191A MR; fast rate (increase in absorption), 490 s
1,
slow rate (decrease in absorption), 40 s
1. C,
kinetic transient observed at 462 nm for the reaction of reduced
wild-type MR with codeinone (2 mM); fast rate (absorption
increase), 104 s
1; slow rate (absorption increase), 15 s
1. D, same as for Panel C but for
C191A MR; fast rate (absorption increase), 29 s
1; slow
rate (absorption increase), 4 s
1.
-strand 3 and
-helix 3 of the core barrel domain that
might confer specificity for the reducing coenzyme. Superposition of
the structure of MR with that of OYE and PETN reductase reveals a high
degree of conservation within the active site, reflecting the ability
of this family of enzymes to reduce "generic" substrates such as
2-cyclohexenone. The active site acid (Tyr-196 and Tyr-186 in OYE and
PETN reductase, respectively) is not conserved in MR and is replaced by
Cys-191. Mutagenesis studies reveal that Cys-191 does not play a
crucial role in the reductive or oxidative half-reactions of MR, thus ruling out a key role as an acid in the reduction of olefinic substrates. A number of alternative potential residues in the active
site of MR may serve as the crucial active site acid required for
reduction of the olefinic bond in 2-cyclohexenone and codeinone.
![]()
FOOTNOTES
A Lister Institute Research Professor. To whom correspondence
may be addressed. Tel.: 44-1-16-223-1337; Fax: 44-1-16-252-3369; E-mail: nss4@le.ac.uk.
![]()
ABBREVIATIONS
-(O2'-6B-cyclo-1,4,5,6-tetrahydronicotinamide
adenine dinucleotide phosphate.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
French, C. E.,
and Bruce, N. C.
(1995)
Biochem. J.
312,
671-678
2.
Melmon, K.,
and Morrelli, H.
(1972)
Clinical Pharmacology: Basic Principles in Therapeutics
, Macmillan Publishing Co., New York
3.
Moffat, A.,
Jackson, J.,
Moss, M.,
and Widdop, B.
(1986)
Clarke's Isolation and Identification of Drugs
, The Pharmaceutical Press, London
4.
Bruce, N.,
French, C.,
Hailes, A.,
Long, M.,
and Rathbone, D.
(1995)
Trends Biotechnol.
13,
200-205
5.
French, C. E.,
Hailes, A. M.,
Rathbone, D. A.,
Long, M. T.,
Willey, D. L.,
and Bruce, N. C.
(1995)
Bio/Technology
13,
674-676
6.
Willey, D. L.,
Caswell, D. A.,
Lowe, C. R.,
and Bruce, N. C.
(1993)
Biochem. J.
290,
539-544
7.
Scrutton, N. S.
(1994)
Bioessays
16,
115-122[CrossRef][Medline]
[Order article via Infotrieve]
8.
Stott, K.,
Saito, K.,
Thiele, D. J.,
and Massey, V.
(1993)
J. Biol. Chem.
268,
6097-6106 9.
Madani, N. D.,
Malloy, P. J.,
Rodriguez-Pombo, P.,
Krishnan, A. V.,
and Feldman, D.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
922-926 10.
French, C. E.,
Nicklin, S.,
and Bruce, N. C.
(1996)
J. Bacteriol.
178,
6623-6627 11.
Snape, J. R.,
Walkley, N. A.,
Morby, A. P.,
Nicklin, S.,
and White, G. F.
(1997)
J. Bacteriol.
179,
7796-7802 12.
Blehert, D. S.,
Fox, B. G.,
and Chambliss, G. H.
(1999)
J. Bacteriol.
181,
6254-6263 13.
Strassner, J.,
Furholz, A.,
Maceroux, P.,
Amrhein, N.,
Schaller, A.,
Schaller, F.,
and Weiler, E.
(1999)
in
Flavins and Flavoproteins
(Ghisla, S.
, Kroneck, P.
, Macheroux, P.
, and Sund, H., eds)
, pp. 655-658, Rudolf Weber, Berlin
14.
Schaller, F.,
and Weiler, E. W.
(1997)
J. Biol. Chem.
272,
28066-28072 15.
Franklund, C. V.,
Baron, S. F.,
and Hylemon, P. B.
(1993)
J. Bacteriol.
175,
3002-3012 16.
Boyd, G.,
Mathews, F. S.,
Packman, L. C.,
and Scrutton, N. S.
(1992)
FEBS Lett.
308,
271-276[CrossRef][Medline]
[Order article via Infotrieve]
17.
Yang, C. C.,
Packman, L. C.,
and Scrutton, N. S.
(1995)
Eur. J. Biochem.
232,
264-271[Medline]
[Order article via Infotrieve]
18.
Liu, X. L.,
and Scopes, R. K.
(1993)
Biochim. Biophys. Acta
1174,
187-190[Medline]
[Order article via Infotrieve]
19.
Lim, L. W.,
Shamala, N.,
Mathews, F. S.,
Steenkamp, D. J.,
Hamlin, R.,
and Xuong, N. H.
(1986)
J. Biol. Chem.
261,
15140-15146 20.
Trickey, P.,
Basran, J.,
Lian, L. Y.,
Chen, Z.,
Barton, J. D.,
Sutcliffe, M. J.,
Scrutton, N. S.,
and Mathews, F. S.
(2000)
Biochemistry
39,
7678-7688[CrossRef][Medline]
[Order article via Infotrieve]
21.
Fox, K. M.,
and Karplus, P. A.
(1994)
Structure
2,
1089-1105[Medline]
[Order article via Infotrieve]
22.
Barna, T.,
Khan, H.,
Bruce, N.,
Barsukov, I.,
Scrutton, N.,
and Moody, P.
(2001)
J. Mol. Biol.
310,
433-447[CrossRef][Medline]
[Order article via Infotrieve]
23.
Vaz, A. D.,
Chakraborty, S.,
and Massey, V.
(1995)
Biochemistry
34,
4246-4256[CrossRef][Medline]
[Order article via Infotrieve]
24.
Williams, R. E.,
Rathbone, D.,
Bruce, N. C.,
Scrutton, N. S.,
Moody, P. C. E.,
and Nicklin, S.
(1999)
in
Flavins and Flavoproteins
(Ghisla, S.
, Kroneck, P.
, Macheroux, P.
, and Sund, H., eds)
, pp. 663-666, Rudolf Weber, Berlin
25.
Williams, R.,
Rathbone, D.,
Moody, P.,
Scrutton, N.,
and Bruce, N.
(2001)
Biochem. Soc. Symp.
68,
143-153
26.
Khan, H.,
Harris, R. J.,
Barna, T.,
Craig, D. H.,
Bruce, N. C.,
Munro, A. W.,
Moody, P. C. E.,
and Scrutton, N. S.
(2002)
J. Biol. Chem.
277,
21906-29012 27.
French, C. E.,
and Bruce, N. C.
(1994)
Biochem. J.
301,
97-103
28.
Moody, P. C. E.,
Shikotra, N.,
French, C. E.,
Bruce, N. C.,
and Scrutton, N. S.
(1997)
Acta Crystallogr. Sect. D Biol. Crystallogr.
53,
619-621[CrossRef][Medline]
[Order article via Infotrieve]
29.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
30.
Brunger, A.
(1997)
Methods Enzymol.
277,
366-396[Medline]
[Order article via Infotrieve]
31.
Navaza, J.
(1994)
Acta Crystallogr. Sect. A
50,
157-163[CrossRef]
32.
Brunger, A.,
Adams, P.,
Clore, G.,
DeLano, W.,
Gros, P.,
Grosse-Kunstleve, R.,
Jiang, J.-S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N.,
Read, R.,
Rice, L.,
Simonson, T.,
and Warren, G.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-929[CrossRef][Medline]
[Order article via Infotrieve]
33.
Read, R.
(1986)
Acta Crystallogr. Sect. A
42,
140-149[CrossRef]
34.
McRee, D.
(1992)
J. Mol. Graphics
10,
44-46[CrossRef]
35.
Kleywegt, G.,
and Jones, T.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
1119-1131[CrossRef][Medline]
[Order article via Infotrieve]
36.
Craig, D. H.,
Moody, P. C. E.,
Bruce, N. C.,
and Scrutton, N. S.
(1998)
Biochemistry
37,
7598-7607[CrossRef][Medline]
[Order article via Infotrieve]
37.
Kohli, R. M.,
and Massey, V.
(1998)
J. Biol. Chem.
273,
32763-32770 38.
Brown, B. J.,
Deng, Z.,
Karplus, P. A.,
and Massey, V.
(1998)
J. Biol. Chem.
273,
32753-32762 39.
Craig, D. H.,
Barna, T.,
Moody, P. C.,
Bruce, N. C.,
Chapman, S. K.,
Munro, A. W.,
and Scrutton, N. S.
(2001)
Biochem. J.
359,
315-323[CrossRef][Medline]
[Order article via Infotrieve]
40.
Muh, U.,
Massey, V.,
and Williams, C. H., Jr.
(1994)
J. Biol. Chem.
269,
7982-7988 41.
Scrutton, D. R.,
Robson, P.,
and Davies, R. M.
(1967)
Nature
213,
950-952[CrossRef][Medline]
[Order article via Infotrieve]
42.
Bocanegra, J. A.,
Scrutton, N. S.,
and Perham, R. N.
(1993)
Biochemistry
32,
2737-2740[CrossRef][Medline]
[Order article via Infotrieve]
43.
Massey, V.,
and Schopfer, L. M.
(1986)
J. Biol. Chem.
261,
1215-1222 44.
Buckman, J.,
and Miller, S. M.
(1998)
Biochemistry
37,
14326-14336[CrossRef][Medline]
[Order article via Infotrieve]
45.
Strickland, S.,
Palmer, G.,
and Massey, V.
(1975)
J. Biol. Chem.
250,
4048-4052 46.
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
23,
946-949[CrossRef]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Breithaupt, R. Kurzbauer, H. Lilie, A. Schaller, J. Strassner, R. Huber, P. Macheroux, and T. Clausen Crystal structure of 12-oxophytodienoate reductase 3 from tomato: Self-inhibition by dimerization PNAS, September 26, 2006; 103(39): 14337 - 14342. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. van den Hemel, A. Brige, S. N. Savvides, and J. Van Beeumen Ligand-induced Conformational Changes in the Capping Subdomain of a Bacterial Old Yellow Enzyme Homologue and Conserved Sequence Fingerprints Provide New Insights into Substrate Binding J. Biol. Chem., September 22, 2006; 281(38): 28152 - 28161. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kitzing, T. B. Fitzpatrick, C. Wilken, J. Sawa, G. P. Bourenkov, P. Macheroux, and T. Clausen The 1.3 A Crystal Structure of the Flavoprotein YqjM Reveals a Novel Class of Old Yellow Enzymes J. Biol. Chem., July 29, 2005; 280(30): 27904 - 27913. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Messiha, N. C. Bruce, B. M. Sattelle, M. J. Sutcliffe, A. W. Munro, and N. S. Scrutton Role of Active Site Residues and Solvent in Proton Transfer and the Modulation of Flavin Reduction Potential in Bacterial Morphinone Reductase J. Biol. Chem., July 22, 2005; 280(29): 27103 - 27110. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Messiha, A. W. Munro, N. C. Bruce, I. Barsukov, and N. S. Scrutton Reaction of Morphinone Reductase with 2-Cyclohexen-1-one and 1-Nitrocyclohexene: PROTON DONATION, LIGAND BINDING, AND THE ROLE OF RESIDUES HISTIDINE 186 AND ASPARAGINE 189 J. Biol. Chem., March 18, 2005; 280(11): 10695 - 10709. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Khan, T. Barna, R. J. Harris, N. C. Bruce, I. Barsukov, A. W. Munro, P. C. E. Moody, and N. S. Scrutton Atomic Resolution Structures and Solution Behavior of Enzyme-Substrate Complexes of Enterobacter cloacae PB2 Pentaerythritol Tetranitrate Reductase: MULTIPLE CONFORMATIONAL STATES AND IMPLICATIONS FOR THE MECHANISM OF NITROAROMATIC EXPLOSIVE DEGRADATION J. Biol. Chem., July 16, 2004; 279(29): 30563 - 30572. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Williams, D. A. Rathbone, N. S. Scrutton, and N. C. Bruce Biotransformation of Explosives by the Old Yellow Enzyme Family of Flavoproteins Appl. Envir. Microbiol., June 1, 2004; 70(6): 3566 - 3574. [Abstract] [Full Text] [PDF] |
||||